The reactive arthritides constitute a group of diverse inflammatory arthropathies in which the joint and extraarticular manifestations are caused by a preceding extraarticular infection with specific bacteria. This chapter reviews…
Pediatric rheumatologists encounter children with acute and chronic pain for which an overt primary cause for the pain cannot be found. In these disorders the pain seems disproportional or amplified….
Episodic color changes of the hands and feet in response to cold or stress, known as Raynaud phenomenon (RP), are a frequent complaint among patients presenting to pediatric rheumatology clinics….
Lyme arthritis was first described in 1977 by Steere and colleagues in a cluster of children thought to have juvenile rheumatoid arthritis. They lived in and around Old Lyme, Connecticut….
Introduction Polyarteritis nodosa (PAN) was first described by Kussmaul and Maier in 1866. The original and subsequent descriptions identified the pathological features of necrotizing arteritis with nodules along the walls…
The term vasculitis indicates the presence of inflammation in a blood vessel wall. The inflammatory infiltrate may be one that is predominantly neutrophilic, eosinophilic, or mononuclear. Perivasculitis describes inflammation around…
Introduction and Historical Review In 1937, the Turkish dermatologist Hulusi Behçet described the syndrome that bears his name, which manifests with the clinical triad of aphthous stomatitis, genital ulceration, and…
Etiology and Pathogenesis Neonatal lupus erythematosus (NLE) is a disease of the developing fetus and neonate defined by characteristic clinical features in the presence of specific maternal autoantibodies. It is…
Definition and Classification Enthesitis-related arthritis (ERA), a term introduced in the International League of Associations for Rheumatology (ILAR) classification of juvenile idiopathic arthritis (JIA), is defined according to the inclusion…
The antiphospholipid syndrome (APS) is an autoimmune multisystem disease characterized by thromboembolic events, pregnancy morbidity, hematological, dermatological, neurological, and other manifestations in the presence of elevated titers of antiphospholipid antibodies…
